Publications – Page 2 – Cegedim Health Data

Les publications : Autoimmune diseases

Accuracy of pneumonia hospital admissions in a primary care electronic medical record database

Meropol SB & Metlay JP

Autoimmune diseases

Pharmacoepidemiology and Drug Safety 2012 doi: 10.1002/pds.3207

Cost-effectiveness of using an extensively hydrolysed formula compared to an amino acid formula as first-line treatment for cow milk allergy in the UK

Taylor RR, Sladkevicius E, Panca M, Lack G & Guest JF

Autoimmune diseases

Pediatric Allergy and Immunology 2012 23(3):240-9

A cohort study to measure the impact of statin therapy on short-term mortality following a pneumonia episode

Douglas I, Evans S & Smeeth L

Autoimmune diseases PharmacoEpidemiology

Society for Academic Primary Care (SAPC) 2011 Bristol

Risk of Myocardial Infarction in UK Primary Care Patients with Hepatitis C Virus Infection

Kimberly Forde K, Kevin Haynes K, James Lewis J & LoRe V

Autoimmune diseases

Pharmacoepidemiology and Drug Safety 2010 (19): S1-S347

Validating Pneumonia Hospitalizations in the THIN Database

Meropol S & Metlay J

Autoimmune diseases

Pharmacoepidemiology and Drug Safety 2010 (19): S1-S347

Incidence rate of community acquired pneumonia in a population cohort registered in BIFAP

Morant S, Bloomfield G, Vats V & Chapple C

Autoimmune diseases

Aten Primaria 2010 42(11):543-9

Resource implications and budget impact of managing cow milk allergy in the UK

Sladkevicius E, Nagy E, Lack G & Guest JF

Autoimmune diseases

Journal of Medical Economics 2010 13(1):119-28

The incidence of pneumonia using data from a computerized general practice database

Myles PR, McKeever TM, Pogson Z, Smith CJ & Hubbard RB

Autoimmune diseases

Epidemiology and Infection 2009 137(5):709-16

Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection

LoRe V, Haynes K, Forde KA, Localio AR, Schinnar R & Lewis JD

Autoimmune diseases

Pharmacoepidemiology and Drug Safety 2009 18(9):807-14

Acid-suppressive drugs and community-acquired pneumonia.

Petersen I, Gilbert R, Ridolfi A, Evans S & Nazareth I

Autoimmune diseases

Epidemiology 2009 20(6):800-6

Pneumonia mortality in a UK general practice population cohort

Myles PR, Hubbard RB, Gibson JE, Pogson Z, Smith CJ & McKeever TM

Autoimmune diseases

European Journal of Public Health 2009 19(5):521-6

Bullous pemphigoid and pemphigus vulgaris -incidence and mortality in the UK: population based cohort study

Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith C J & West J

Autoimmune diseases Dermatology

British Medical Journal (BMJ) 2008 337(a180)